Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase EARLY_PHASE1 1Phase 3 1

Status

Completed 149Unknown 45Terminated 43Recruiting 32Active not recruiting 22Not yet recruiting 10Withdrawn 7Enrolling by invitation 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Neoplasms 2Myasthenia Gravis 2Leukemia, Myeloid, Acute 2Radiodermatitis 1Neurotoxicity Syndromes 1Myelodysplastic Syndromes 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Gallbladder Neoplasms 1Fibrosis 1Esophageal Squamous Cell Carcinoma 1Depression 1Cognitive Dysfunction 1Chemotherapy-Related Cognitive Impairment 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1Carcinoma 1Breast Neoplasms 1Breast Cancer Metastatic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Enrolling by invitation × Lung Neoplasms × Clear all
NCT06281964 2026-04-23

KANNON-2

Avistone Biotechnology Co., Ltd.

Phase 3 Enrolling by invitation
327 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡